Replies to post #49195 on Biotech Values

[DewDiligence]

>Given MDCO's expertise in marketing, I'm sure they'll be able to ramp up Angiomax sales in Europe.<

Maybe.

The move still comes across as an act of desperation to divert attention from the U.S. market.